| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3080303 | Neuromuscular Disorders | 2008 | 5 Pages |
Abstract
The discrepancy between the evolution of clinical features and the evolution of QoL and disability may be due to the development of compensatory strategies that help patients cope with the slow progression of the disease. Our observations provide information which may be useful when designing clinical trials in CMT.
Related Topics
Life Sciences
Neuroscience
Developmental Neuroscience
Authors
L. Padua, D. Pareyson, I. Aprile, T. Cavallaro, A. Quattrone, N. Rizzuto, G. Vita, P. Tonali, A. Schenone,